Lesaka Technologies posts revenue growth but $54M fair-value hit, restatement and control weaknesses

Quick read - Company (NASDAQ: UEPS)

Note: the income-statement and filing text you provided are for Lesaka Technologies, Inc. (SEC file 0001041514). Below I report the facts and figures from that filing but formatted as you requested.

Key facts & headline figures (as reported)
* Revenue - Three months ended Mar 31, 2025: $161,450; Three months Mar 31, 2024: $138,194 (restated +$25,780 for Q3).
* Revenue - Nine months ended Mar 31, 2025: $491,234; 2024: $418,176 (restated +$63,200 YTD).
* Cost of goods sold (COGS) - Q3 2025: $117,013; YTD: $366,618.
* Gross operating income - Operating income Q3 2025: $569; YTD: $1,301.
* Fair value hit - Change in fair value of equity securities: Q3 $(20,421); YTD $(54,152) (MobiKwik adjustment).
* Net loss - Q3 2025: $(22,038); Q3 2024: $(4,047). YTD net loss Mar 31, 2025: $(58,686); 2024: $(12,405).
* Net loss attributable to company - Q3: $(22,058); YTD: $(58,734). Basic EPS Q3: $(0.27); YTD: $(0.81).
* Cash & equivalents: $71,008 (Mar 31, 2025) vs $59,065 (June 30, 2024). Total assets: $649,198. Total liabilities: $368,220.
* Long-term borrowings (net): $166,612; current portion of long-term borrowings: $28,088. Redeemable common stock: $88,957.
* Goodwill & intangibles: Goodwill $209,836; Intangible assets, net $142,158 (amortization rising).
* Finance loans receivable (net): $61,261. Accounts receivable & other receivables: $36,127.
* Operating cash flow - Q3 provided $10,663; YTD used $(2,639). Investing YTD used $(21,219). Financing YTD provided $29,893.

Positive signals
* Revenue growth: +17% year-over-year (both Q3 and YTD in USD; +14% / +13% in ZAR). Restatement increased reported revenue (correction to principal vs agent treatment).
* Improving operating cash in quarter: Q3 operating cash provided $10.7M despite YTD cash use - shows quarter-level operating conversion when seasonality and settlement timing align.
* Strategic M&A: Adumo (Oct 2024) and Recharger (Mar 2025) are integrated contributors - they materially increased merchant and enterprise capabilities and explain the larger goodwill and intangibles balances (goodwill now $209.8M).
* Segment profitability (non-GAAP): Group Adjusted EBITDA positive - Q3 $12.8M; YTD $34.0M - underlying operations generate EBITDA before acquisition, FV and financing items.
* Cash balance up from June 30, 2024: $71.0M vs $59.1M - liquidity increased even after acquisitions and capex.

Negative / risk items (income statement & controls)
* Large non-cash fair-value losses: $(20.4M) in Q3 and $(54.2M) YTD driven by the MobiKwik revaluation - this single item is the primary drag on net income.
* Material restatement and controls failure: management restated revenue and COGS (Q3 +$25.8M; YTD +$63.2M) and concluded material weaknesses in internal control over financial reporting - internal control not effective as of Mar 31, 2025. That raises execution and disclosure risk.
* Rising interest expense and leverage: Interest expense Q3 $5.78M (YTD $16.98M). Long-term borrowings rose (new Feb 2025 facilities) - higher finance cost pressures future net income and margins.
* Thin operating profit: Operating income Q3 only $0.57M (margin ~0.4% on $161.45M revenue); YTD operating income $1.30M - operational margins compressed after acquisition amortization and higher SG&A.
* Increased SG&A and amortization: SG&A Q3 $34.2M (+48% YoY); Depreciation & amortization Q3 $8.43M (+46% YoY) - acquisition-related amortization materially increases expense run-rate.
* Net loss per share materially negative: Basic (loss) per share Q3 $(0.27), YTD $(0.81) - dilutive to shareholder returns.
* YTD operating cash used: $(2.6M) despite quarter improvement; investing cash used $(21.2M) YTD and sizable financing/debt moves - cash burn in aggregation if EBITDA slips.
* Concentration of loss drivers: FV swings (equity securities) and impairment sensitivity (Cell C shown at $0) create earnings volatility.

What to watch next - practical checklist
* Control remediation: progress, test results and auditor comments on remediation of the material weaknesses (revenue recognition, journal controls, goodwill testing).
* Fair-value volatility: any further MobiKwik or other equity write-downs; management commentary on recoverability of those investments.
* Debt profile & cost: covenant status, upcoming maturities (current portion $28.1M), interest margins (JIBAR/prime-linked) and liquidity headroom under the new CTA facilities.
* Integration & synergies: actual contribution from Adumo and Recharger vs pro forma expectations (revenue, margin, loan book growth).
* Consumer lending quality: allowance for credit losses trends (micro & merchant loans: total finance loans receivable net $61.26M) and portfolio loss rates; separate lending facility progress.
* Operating cash conversion: sustain Q3 positive operating cash flow into Q4 and reduce reliance on short-term overdrafts.

Bottom line (straightforward)
* The company shows real revenue growth and segment EBITDA, and recent acquisitions expand capability - but net profits are being wiped out by large non‑cash fair-value losses, higher amortization and interest. The restatement and admitted material weaknesses are red flags: they increase execution, disclosure and enforcement risk. Monitor remediation progress, fair-value volatility and debt servicing closely before drawing a positive valuation conclusion.

If you want, I can convert these points into a one‑page investor memo or a short headline alert for publication.